MOFECON S 360MG TABLET

Mofecon S 360 mg tablet is an immunosuppressant with an active ingredient known as Mycophenolate sodium. It is part of the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop organ rejection in patients who have had one of their organs (such as heart, kidney transplantation, or liver). It is usually prescribed as part of a treatment combination which includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. This medication should not be used during pregnancy unless there are other alternatives and the advantages outweigh the risks. Women with reproductive potential should be advised to utilize an effective contraceptive tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered when a patient is using Mofecon S 360mg tablet due to a decrease in the vaccine’s effectiveness and the risk of getting ill. Patients taking this medication must not give blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood donation.
It is recommended not to take this drug when allergic to the medication or other components. Tell your doctor if you suffer from heart disease or liver problems before beginning treatment. Because this drug weakens the body’s immune system, it increases the risk of developing skin cancer. People should minimize their exposure to UV (UV) ultraviolet (UV) light. Consult your physician immediately when you experience bruises on your skin, fever or any other unidentified fatigue, dizziness or discolouration of the skin, eyes or eyes, vision impairment, decreased urine output, or seizures after taking this medication. Mofecon S 360 mg tablet is an immunosuppressive medication. It can affect a baby’s developing immune system and should be avoided while breastfeeding.